HDL Cholesterol and Risk of Type 2 Diabetes: A Mendelian Randomization Study
暂无分享,去创建一个
[1] B. Nordestgaard,et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.
[2] D. Sviridov,et al. Effects of High-Density Lipoprotein Elevation With Cholesteryl Ester Transfer Protein Inhibition on Insulin Secretion , 2013, Circulation research.
[3] M. Linton,et al. Killing two birds with one stone, maybe: CETP inhibition increases both high-density lipoprotein levels and insulin secretion. , 2013, Circulation research.
[4] D. Sviridov,et al. Effects of HDL Elevation with CETP Inhibition on Insulin Secretion , 2013 .
[5] Sonia Shah,et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study , 2013, The Lancet.
[6] B. Nordestgaard,et al. ABC Transporter Genes and Risk of Type 2 Diabetes , 2012, Diabetes Care.
[7] Tanya M. Teslovich,et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes , 2012, Nature Genetics.
[8] Claude Bouchard,et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance , 2012, Nature Genetics.
[9] P. Barter,et al. The emerging role of HDL in glucose metabolism , 2012, Nature Reviews Endocrinology.
[10] Mark I. McCarthy,et al. Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance , 2011, Diabetes.
[11] P. Barter,et al. Effects of High-Density Lipoproteins on Pancreatic &bgr;-Cell Insulin Secretion , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[12] C. Hedrick,et al. An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. , 2010, The Journal of clinical investigation.
[13] Lukasz Januszkiewicz. [The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus]. , 2010, Kardiologia polska.
[14] John B Buse,et al. Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.
[15] D. Sviridov,et al. High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.
[16] M. Hayden,et al. Carriers of Loss-of-Function Mutations in ABCA1 Display Pancreatic β-Cell Dysfunction , 2008, Diabetes Care.
[17] Børge G Nordestgaard,et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. , 2008, JAMA.
[18] C. Aguilar-Salinas,et al. Association of the ATP-Binding Cassette Transporter A1 R230C Variant With Early-Onset Type 2 Diabetes in a Mexican Population , 2008, Diabetes.
[19] R. Lai,et al. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism , 2007, Diabetologia.
[20] Ralph B D'Agostino,et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. , 2007, Archives of internal medicine.
[21] James D. Johnson,et al. β-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment , 2007, Nature Medicine.
[22] Heejung Bang,et al. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. , 2005, Diabetes care.
[23] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[24] I. Stratton,et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.
[25] P. Toth. LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals , 2012 .
[26] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[27] M. Taskinen. Diabetic dyslipidemia. , 2002, Atherosclerosis. Supplements.
[28] 武井泉,et al. United Kingdom Prospective Diabetes Study (UKPDS) , 1999 .